Dr. John Woolley – Head of Biomarkers

Dr. John Woolley leads Biomarker discovery and Bioinformatics at Sygnature Discovery. He has a background in genetics and molecular biology and has over a decade of experience leading translational research teams across disease indications. He has published widely in areas of target identification and validation, mechanistic studies and biomarker discovery across multiple drug modalities. He specializes in integrating deep data to support early discovery programs, anchoring credible target biology with disease context.